Fase I Clinical Trial on NK Cells for COVID-19
NCT04634370
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Sars-cov 2
Interventions
BIOLOGICAL:
Natural Killer Cells infusion
Sponsor
Hospital de Clinicas de Porto Alegre